Stocks and Investing Stocks and Investing
Fri, August 2, 2024

Gena Wang Maintained (VIR) at Buy with Increased Target to $28 on, Aug 2nd, 2024


Published on 2024-10-28 13:04:26 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Vir Biotechnology, Inc." (VIR) at Buy with Increased Target from $27 to $28 on, Aug 2nd, 2024.

Gena has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michelle Gilson of "Morgan Stanley" Maintained at Hold with Increased Target to $15 on, Thursday, June 6th, 2024
  • Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $12 on, Friday, May 3rd, 2024


These are the ratings of the 2 analyists that currently disagree with Gena


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $110 on, Wednesday, June 5th, 2024
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $19 on, Wednesday, June 5th, 2024
Contributing Sources